isoselenocyanic-acid and Leishmaniasis--Cutaneous

isoselenocyanic-acid has been researched along with Leishmaniasis--Cutaneous* in 1 studies

Other Studies

1 other study(ies) available for isoselenocyanic-acid and Leishmaniasis--Cutaneous

Article	Year
Leishmanicidal Activity of Isoselenocyanate Derivatives. Antimicrobial agents and chemotherapy, 2019, Volume: 63, Issue:2 Conventional chemotherapy against leishmaniasis includes agents exhibiting considerable toxicity. In addition, reports of drug resistance are not uncommon. Thus, safe and effective therapies are urgently needed. Isoselenocyanate compounds have recently been identified with potential antitumor activity. It is well known that some antitumor agents demonstrate effects against Topics: Amphotericin B; Animals; Antiprotozoal Agents; Cell Cycle Checkpoints; Leishmania major; Leishmania mexicana; Leishmaniasis, Cutaneous; Macrophages, Peritoneal; Mice; Mice, Inbred BALB C; Organoselenium Compounds; Sulfur Compounds	2019

Article

Year

Leishmanicidal Activity of Isoselenocyanate Derivatives.

Antimicrobial agents and chemotherapy, 2019, Volume: 63, Issue:2

Conventional chemotherapy against leishmaniasis includes agents exhibiting considerable toxicity. In addition, reports of drug resistance are not uncommon. Thus, safe and effective therapies are urgently needed. Isoselenocyanate compounds have recently been identified with potential antitumor activity. It is well known that some antitumor agents demonstrate effects against

Topics: Amphotericin B; Animals; Antiprotozoal Agents; Cell Cycle Checkpoints; Leishmania major; Leishmania mexicana; Leishmaniasis, Cutaneous; Macrophages, Peritoneal; Mice; Mice, Inbred BALB C; Organoselenium Compounds; Sulfur Compounds

2019